
July 21 (Reuters) - Sarepta Therapeutics Inc SRPT.O:
SAREPTA THERAPEUTICS INC - FDA PLACES CLINICAL HOLD ON SAREPTA'S LGMD TRIALS - SEC FILING
SAREPTA THERAPEUTICS INC - HOLD INCLUDES SAREPTA'S SRP-9003, SRP-9004, SRP-6004, SRP-9005 TRIALS - SEC FILING
SAREPTA THERAPEUTICS INC - FDA REVOKES DESIGNATION FOR SAREPTA'S AAVRH74 PLATFORM - SEC FILING
SAREPTA THERAPEUTICS INC - FDA PLACES CLINICAL HOLD ON SAREPTA'S LGMD TRIALS - SEC FILING
Source text: [ID:n0001193125-25-161516]